James M. Mock
At a glance: James M. Mock is CFO at Moderna (MRNA). Their latest SEC Form 4, filed Sep 14, 2026, reported a sale of $2.7M. On file: 0 purchase lines ($0) and 2 sale lines ($4.7M).
Disclosed holdings: about $11.9M of MRNA stock: 59,375 shares reported on their latest Form 4 (filed Sep 14, 2026), valued at the Nov 19, 2026 close of $200.20. This counts only MRNA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CFO at Moderna, Inc. (MRNA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
James M. Mock's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 14SEC | MRNAModerna, Inc. | Sell Plan | 19,83674,375 held (−21%) | $134.49 | $2.7M | +48.9% |
| Sep 14SEC | MRNAModerna, Inc. | Sell Plan | 15,00059,375 held (−20%) | $134.49 | $2.0M | +48.9% |
- Sell
CFO James M Mock sold $2.7M of MRNA at $134.49 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO James M Mock sold $2.0M of MRNA at $134.49 — pre-scheduled 10b5-1 plan sale.
Follow James M. Mock
Get one email when James M. Mock files a new purchase or sale. Free.
At most one email a day about James M. Mock, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.